Dormotech Medical Inc.

Dormotech Medical Inc. is a medical device manufacturer specializing in wireless sleep diagnostic systems. The company develops and markets DormoVision X™, a comprehensive polysomnography (PSG) platform designed for both home sleep apnea testing (HSAT) and in-laboratory sleep studies. The system captures 29 direct physiological channels and 9 derived channels, including EEG, EOG, chin EMG, ECG, SpO₂, nasal/oral airflow, respiratory effort, snoring/breathing sounds, body and head position, and modular ExG measurements for leg, limb, and chest activity. DormoVision X™ is cloud-based and wireless, eliminating traditional wired equipment complexity while delivering in-lab quality diagnostic data. The platform supports all three sleep study types (Type 1, 2, and 3) and accommodates pediatric patients age 6 and older with patient-friendly wireless sensors and soft materials. Clinical validation demonstrates 97% equivalence with traditional in-lab PSG. The system enables unlimited multi-night testing to capture night-to-night variability and includes automated AI-driven analysis for sleep staging, arousal detection, and event classification. Dormotech targets sleep medicine clinics, hospitals, and diagnostic centers seeking to expand capacity without adding physical lab beds or overhead. The usage-based, scalable cloud model supports expansion across multiple locations. The company is recognized for innovation in sleep medicine and maintains an advisory board of leading sleep medicine physicians and researchers.